Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.
Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R. Paur I, et al. Among authors: eri lm. Clin Nutr. 2017 Jun;36(3):672-679. doi: 10.1016/j.clnu.2016.06.014. Epub 2016 Jun 30. Clin Nutr. 2017. PMID: 27406859 Free article. Clinical Trial.
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.
Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O. Baco E, et al. Among authors: eri lm. Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7. Eur Urol. 2016. PMID: 25862143 Free article. Clinical Trial.
The effect of bicalutamide on prostate histology.
Eri LM, Svindland A, Tveter KJ. Eri LM, et al. Prostate. 2001 Mar 1;46(4):275-80. doi: 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2. Prostate. 2001. PMID: 11241549
No randomised trial of prostate-cancer screening in Norway.
Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L; Norwegian Urological Cancer Group. Fosså SD, et al. Among authors: eri lm. Lancet Oncol. 2001 Dec;2(12):741-5; discussion 746-9. doi: 10.1016/S1470-2045(01)00588-5. Lancet Oncol. 2001. PMID: 11902516 Review.
PBX3 is a putative biomarker of aggressive prostate cancer.
Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA. Ramberg H, et al. Among authors: eri lm. Int J Cancer. 2016 Oct 15;139(8):1810-20. doi: 10.1002/ijc.30220. Epub 2016 Jun 25. Int J Cancer. 2016. PMID: 27273830 Free article.
62 results